Bulletin
Investor Alert

New York Markets After Hours

Market Pulse Archives

Oct. 27, 2021, 8:48 a.m. EDT

Novavax is seeking authorization in the U.K. for its COVID-19 vaccine

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Novavax Inc. (NVAX)
  • X
    BioNTech SE ADR (BNTX)
  • X
    Pfizer Inc. (PFE)

or Cancel Already have a watchlist? Log In

By Jaimy Lee

Shares of Novavax Inc. /zigman2/quotes/202614340/composite NVAX -15.93% jumped 8.0% in premarket trading on Wednesday after the company said it began submitting its experimental COVID-19 vaccine for authorization in the U.K. Novavax's vaccine candidate is protein-based, meaning it's a different type of vaccine than the mRNA shots developed by BioNTech SE /zigman2/quotes/214419716/composite BNTX -0.30% /Pfizer Inc. /zigman2/quotes/202877789/composite PFE -3.00% and Moderna Inc. /zigman2/quotes/205619834/composite MRNA -2.94% or the ChAdOx1 technology used in the AstraZeneca /zigman2/quotes/200304487/composite AZN -0.16% shots. Novavax's vaccine came out of clinical trials in the U.K. with an overall efficacy rate of 89.7%. The company plans to submit its vaccine candidate to U.S. regulators by the end of the year. Novavax's stock is up 21.0% for the year, while the S&P 500 /zigman2/quotes/210599714/realtime SPX +1.42% has gained 21.8%.

/zigman2/quotes/202614340/composite
US : U.S.: Nasdaq
$ 161.97
-30.68 -15.93%
Volume: 11.83M
Dec. 2, 2021 4:00p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$14.57 billion
Rev. per Employee
$601,262
loading...
/zigman2/quotes/214419716/composite
US : U.S.: Nasdaq
$ 333.49
-0.99 -0.30%
Volume: 4.10M
Dec. 2, 2021 4:00p
P/E Ratio
9.63
Dividend Yield
N/A
Market Cap
$81.12 billion
Rev. per Employee
$283,276
loading...
/zigman2/quotes/202877789/composite
US : U.S.: NYSE
$ 53.04
-1.64 -3.00%
Volume: 46.28M
Dec. 2, 2021 4:02p
P/E Ratio
15.74
Dividend Yield
2.94%
Market Cap
$306.91 billion
Rev. per Employee
$533,860
loading...
/zigman2/quotes/205619834/composite
US : U.S.: Nasdaq
$ 301.49
-9.12 -2.94%
Volume: 15.35M
Dec. 2, 2021 4:00p
P/E Ratio
18.52
Dividend Yield
N/A
Market Cap
$125.94 billion
Rev. per Employee
$617,996
loading...
/zigman2/quotes/200304487/composite
US : U.S.: Nasdaq
$ 54.79
-0.09 -0.16%
Volume: 5.36M
Dec. 2, 2021 4:00p
P/E Ratio
86.47
Dividend Yield
2.50%
Market Cap
$171.53 billion
Rev. per Employee
$362,602
loading...
/zigman2/quotes/210599714/realtime
US : S&P US
4,577.10
+64.06 +1.42%
Volume: 2.80B
Dec. 2, 2021 5:08p
loading...

This Story has 0 Comments
Be the first to comment
More News In
Industries

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.